Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women

Calcified Tissue International

Volumn 66, Issue 6, 2000, Pages 414-418

  Haden, S T ^a   Glowacki, J ^a   Hurwitz, S ^a   Rosen, C ^b   LeBoff, M S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

Age; DHEAS; IGF I; IL 6

Indexed keywords

INTERLEUKIN 6; PRASTERONE SULFATE; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SPINE;

ADULT; AGED; AGING; BONE DENSITY; DEHYDROEPIANDROSTERONE SULFATE; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREMENOPAUSE; RADIOIMMUNOASSAY;

EID: 0034119483     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010084     Document Type: Article

References (31)

1. LeBoff MS, Glowacki J (1999) Sex steroids, aging, and bone. In: Rosen C, Glowacki J, Bilezikian J (eds) The aging skeleton. Academic Press, San Diego, pp 149-162
2. Migeon CJ, Keller AR, Lawrence B, Shepart TH (1957) Dehydroepiandrosterone and androsterone levels in human placenta. Effect of age and sex: day-to-day and diurnal variations. J Clin Endocrinol Metab 17:1051-1062
3. Orentreich NJ, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:187-191
4. Bélanger AB, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79:1086-1090
5. Mortola JF, Yen SSC (1990) The effects of oral dehydroepiandrosterone (DHEA) on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696-704
6. Morales AJ, Nolan JJ, Nelson JC, Yen SSC (1994) Effects of replacement dose of dehydroepiandrosterone (DHEA) in men and women of advancing age. J Clin Endocrinol Metab 78: 1360-1367
7. Wei J, Xu H, Davies JL, Hemmings GP (1992) Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51:1953-1956
8. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41:176-181
9. Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R (1993) Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymph Lyto Res 12:225-230
10. Kania DM, Brinkley N, Checovich M, Havighurst T, Schilling M, Ershler WB (1995) Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 43(3):236-239
11. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B (1998) Serum dehydroepiandrosterone (DHEA) and DHEAS sulfate are negatively correlated with serum interleukin IL-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83:2012-2017
12. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y (1993) Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in DHEA and its sulfated derivative. J Immunol 150(11):5219-5230
13. Grogean T, Vereault D, Millard PS, Kiel D, MacLean D, Orwoll E, Greenspan S, Rosen CJ (1997) A comparative analysis of methods to measure IGF-I in human serum. Endocrinol Metab 4:109-114
14. El-Hajj Fuleihan G, Testa MA, Angell JE, Porrino N, LeBoff MS (1995) Reproducibility of DXA absorptiometry: a model for bone loss estimates. J Bone Miner Res 10(7):1004-1014
15. Taelman P, Kaufman JM, Janssens X, Vermeulen A (1989) Persistence of increased bone resorption and the possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause. Maturitas 1: 65-73
16. Liu CH, Laughlin GA, Fisher UG, Yen SSC (1990) Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone (DHEA) in postmenopausal women: evidence of reduced 17,20 desmolase enzyme activity. J Clin Endocrinol Metab 71:696-704
17. Greendale GG, Edelstein S. Barrett-Connor (1997) Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernado study. J Bone Miner Res 12: 1833-1843
18. Barrett-Connor E, Goodman-Gruen D (1998) Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernado study. J Bone Miner Res 13:1343-1349
19. Langlois JA, Rosen CJ, Visser M, Hannan M, Harris T, Wilson PFW, Kiel D (1998) The association between IGF-I and bone mineral density in women and men: the Framingham heart study. J Clin Endocrinol Metab 83:4257-4262
20. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
21. Jilka RL, Hangoc G, Girasole G, Passweri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
22. Labrie F, Belanger A, Cusan L, Candas B (1997) Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 82: 2403-2409
23. Spencer NF, Norton SD, Harrison LL, Li GZ, Daynes RA (1996) Disregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 31:393-408
24. Bellido T, Jilka RL, Boyce BF, Girasde G, Broxmeyer H, Balrymple SA, Murray R, Manolagas SC (1995) Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 95: 2885-2895
25. Nordin BEC, Robertson A, Seamark RF, Bridges A, Philcox JC, Need AG, Horowitz M, Morris HA, Deam S (1985) The relation between calcium absorption, serum dehydroepiandrosterone and vertebral mineral density in postmenopausal women. J Clin Endocrinol Metab 60:651-657
26. Barrett-Connor E, Kritz-Silverstein D, Edelstein SL (1993) A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women, Am J Epidemiol 137:201-206
27. LeBoff MS, Rosen C, Rightmire E, Glowacki J (1995) Changes in growth factors and cytokines in postmenopausal women (abstract). J Bone Miner Res 10(1):M370
28. Lynda Lee YS, Kohlmeier L, van Vollenhoven R, Marcus R, Mcguire J (1993) The effect of DHEA on mineral metabolism in healthy postmenopausal women (abstract). Am Col Rheum
29. Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, LeBoff MS (1999) Changes in the bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 14:136-145
30. Rosen CJ, Verault D, Steffens C, Cheleuitte D, Glowacki J (1997) Effects of age and estrogen status on the skeletal IGF regulatory system: studies with human marrow. Endocrine 7:77-80
31. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL (1998) Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 62:60-66